Form D — Mediar Therapeutics, Inc.
0001766784-25-000002 · filed Dec 23, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $75,699,630
- Total sold
- $37,849,815
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Mediar Therapeutics, Inc.
- CIK
- 1766784
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 20 OVERLAND STREET
BOSTON, MA 02215 - Phone
- 617-936-0960
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Rahul Ballal · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Cassidy Blundell · DirectorBoston, MA Find on LinkedIn ↗
-
Marie-Claire Peakman · DirectorBoston, MA Find on LinkedIn ↗
-
Adam Cotton · DirectorBoston, MA Find on LinkedIn ↗
-
Maina Bhaman · DirectorBoston, MA Find on LinkedIn ↗
-
Andreas Jurgeit · DirectorBoston, MA Find on LinkedIn ↗
-
Bharat Srinivasa · DirectorBoston, MA Find on LinkedIn ↗
-
Simon Sturge · DirectorBoston, MA Find on LinkedIn ↗
-
Allan Marchington · DirectorBoston, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗